Clinical trial
Safety & Efficacy Study Using Topiramate in Posttraumatic Stress Disorder
NCT00204386 · University of Oklahoma, Other · Completed
Key facts
| NCT number | NCT00204386 |
|---|---|
| Title | Safety & Efficacy Study Using Topiramate in Posttraumatic Stress Disorder |
| Official title | A Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Determine the Efficacy and Safety of Topiramate in the Treatment of Posttraumatic Stress Disorder |
| Lead sponsor | University of Oklahoma, Other |
| Collaborators | Ortho-McNeil Neurologics, Inc. Industry |
| Status | Completed |
| Phase | Phase 2/Phase 3 |
| Study type | Interventional |
| Conditions | Posttraumatic Stress Disorder |
| Intervention type | Drug |
| Interventions | Topiramate |
| Enrollment | 50 |
| Start date | Sep 1, 2002 |
| Completion | May 1, 2007 |
| First posted | Sep 20, 2005 |
| Last update posted | May 30, 2007 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: